A Clinical Study to Assess the Effect of a Dietary Supplement on Menstrual Cycle Symptoms (NCT07267728) | Clinical Trial Compass
CompletedNot Applicable
A Clinical Study to Assess the Effect of a Dietary Supplement on Menstrual Cycle Symptoms
United States40 participantsStarted 2025-02-01
Plain-language summary
This is a single-group, virtual clinical trial evaluating the effects of a daily dietary supplement (DITTO Cycle Supplement) on menstrual cycle symptoms across three menstrual cycles. The study investigates changes in symptom severity and quality of life through validated questionnaires including the Menstrual Symptoms Questionnaire (MSQ).
Who can participate
Age range18 Years – 45 Years
SexFEMALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Female-at-birth
* Aged 18-45
* In the last three menstrual cycles, has experienced three or more of the following symptoms associated with their menstrual cycle: Menstrual cramps, Bloating, Breast tenderness, Headaches, Fatigue, Muscle aches and/or joint pain, Cravings, Mood swings, Low mood, Feelings of anxiety, Irritability, Difficulty concentrating
* Generally healthy - does not live with any uncontrolled chronic disease
* Has a regular menstrual cycle length, between 23 and 35 days
* Tracks their menstrual cycle and can predict their period dates
* Anyone willing to comply with study requirements
* Anyone with no known allergies to the ingredients listed in the product
Exclusion Criteria:
* Anyone with pre-existing chronic conditions that would prevent participants from adhering to the protocol, including oncological and psychiatric disorders
* Women who are pregnant, breastfeeding, or trying to conceive
* Anyone unwilling to follow the study protocol
* Anyone in perimenopause, menopause, or experiencing menopausal-type symptoms
* Anyone with planned surgery during the study period
* Anyone with a history of substance abuse
* Anyone diagnosed with high blood pressure, high cholesterol, heart disease, heart attack, stroke, irregular heartbeat (AFib), clogged arteries, poor circulation, heart failure, or other heart conditions
* Anyone diagnosed with a hormone or reproductive health-related cancer or benign condition
* Anyone diagnosed with a menstr…
What they're measuring
1
Change in Menstrual Symptoms Questionnaire (MSQ) Scores
Timeframe: Baseline, End of Cycle 1(28 days), End of Cycle 2(28 days), End of Cycle 3 (28 days)